AKTIIA OBPM to Assess CPAP Effect on Blood Pressure in Obstructive Sleep Apnea
Launched by HOSPITAL UNIVERSITARIO ARABA · May 31, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Patients with moderate-severe OSA, indication for CPAP therapy and undiagnosed hypertension will be included. If the patient meets all the inclusion criteria and none of the exclusion criteria, he/she will be considered a candidate for the study. Once the informed consent has been signed, a visit will be made to initiate continuous blood pressure monitoring with the AKTIIA system (AKTIIA OBPM). The first week (week 0, preCPAP) serves to confirm the presence of HBP (average BP 130/80+ mmHg and/or average nocturnal BP 120/70+ mmHg).
If the participant has HBP criteria, an speckle tracking ec...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults 25-70 years old
- • Moderate-severe OSA (AHI 15+)
- • First prescription of CPAP therapy
- • Undiagnosed HBP
- • Smartphone use and technological skills
- • Informed consent
- Exclusion Criteria:
- • Antihypertensive drug
- • Cardiovascular comorbidity: atrial fibrilation, heart failure, ischemic heart disease, stroke
- • Reduced perfusion (e.g. Raynaud)
- • Severe/Advanced chronic disease
- • Central apnea
- • Pregnancy
- • Shift work
- • Other social issues: misunderstanding/miscommunication
Trial Officials
Mikel Azpiazu, MD
Principal Investigator
Hospital Universitario Araba
About Hospital Universitario Araba
Hospital Universitario Araba is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. Located in Vitoria-Gasteiz, Spain, this university hospital is affiliated with the University of the Basque Country, fostering a collaborative environment that bridges clinical practice and academic excellence. Committed to improving patient outcomes, Hospital Universitario Araba actively participates in a range of clinical studies across various specialties, facilitating the development of cutting-edge treatments and contributing to the global medical community's knowledge base. With a focus on patient safety and ethical standards, the hospital ensures rigorous adherence to regulatory requirements while promoting a culture of scientific inquiry and excellence in patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vitoria Gasteiz, Araba, Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0